Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 2/20 | 0.32 |
| ▸ | CDC25B | P30305 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304605 | 0.83 | — | — | |
| SCHEMBL304331 | 0.77 | CDC25A (0.31) | CDC25ACDC25B | |
| SCHEMBL15201154 | 0.75 | — | — | |
| SCHEMBL3413343 | 0.70 | CDC25A (0.37) | CDC25ACDC25B | |
| SCHEMBL16201653 | 0.60 | CDC25A (0.32) | CDC25ACDC25B | |
| SCHEMBL12851540 | 0.60 | TOP2A (0.31) | TDP1ALDH1A1 | |
| SCHEMBL16201624 | 0.60 | CDC25A (0.32) | CDC25ACDC25B | |
| SCHEMBL22654547 | 0.60 | ALOX15 (0.37) | ALOX15TDP1TSHRALDH1A1 | |
| SCHEMBL5587224 | 0.58 | CDC25A (0.36) | CDC25ACDC25B | |
| SCHEMBL5587123 | 0.58 | CES2 (0.39) | CDC25ACDC25BALOX15TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113024724-B | Method for continuous polymerization of cracked fractions | 清华大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-113136239-B | Utilization method of ethylene cracking tar and application of compound containing carbon-carbon double bond | 清华大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-113563152-A | Method for treating C five fraction and use of olefinic bond-containing compound | 清华大学 | 2021-10-29 | — | — | CN | disclosed |
| CN-113136239-A | Utilization method of ethylene cracking tar and application of compound containing carbon-carbon double bond | 清华大学 | 2021-07-20 | — | — | CN | disclosed |
| CN-113122315-A | Method for treating ethylene tar and use of carbonyl compound containing olefinic bond | 清华大学 | 2021-07-16 | — | — | CN | disclosed |
| CN-113024724-A | Method for continuous polymerization of cracked fractions | 清华大学 | 2021-06-25 | — | — | CN | disclosed |
| CN-112852482-A | Method for treating cracked fractions and use of compounds containing olefinic bonds | 清华大学 | 2021-05-28 | — | — | CN | disclosed |
| US-20160151322-A1 | METALLO-B-LACTAMASE INHIBITORS | MEIJI SEIKA KAISHA (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160151322-A1 | METALLO-B-LACTAMASE INHIBITORS | MEIJI SEIKA KAISHA (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160151322-A1 | METALLO-B-LACTAMASE INHIBITORS | MEIJI SEIKA KAISHA (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-1941873-A1 | METALLO-BETA-LACTAMASE INHIBITOR | MEIJI SEIKA KAISHA LTD. (JP) | 2008-07-09 | — | — | EP | disclosed |
| US-20080090825-A1 | Metallo-beta-lactamase inhibitors | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20080090825-A1 | Metallo-beta-lactamase inhibitors | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20080090825-A1 | Metallo-beta-lactamase inhibitors | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-5145916-A | Heat resistant adhesive for aircraft and spacecraft | UBE INDUSTRIES, LTD. (JP) | 1992-09-08 | — | — | US | disclosed |
| EP-0395020-A2 | Terminal-modified imide oligomer composition | UBE INDUSTRIES, LTD. (JP) | 1990-10-31 | — | — | EP | disclosed |
| US-4963645-A | UNSATURATED END GROUPS | UBE INDUSTRIES, LTD. (JP) | 1990-10-16 | — | — | US | disclosed |
| US-4921745-A | Honeycomb structure of aromatic polyimide | UBE INDUSTRIES, LTD. (JP) | 1990-05-01 | — | — | US | disclosed |
| EP-0304913-A2 | Terminal-modified imide oligomer and solution composition of the same | UBE INDUSTRIES, LTD. (JP) | 1989-03-01 | — | — | EP | disclosed |
| US-4375974-A | OLEFIN POLYMER-UNSATURATED ANHYDRIDE-POLYAMINE REACTION PRODUCT | INSTITUT FRANCAIS DU PETROLE (FR) | 1983-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090825-A1 | Metallo-beta-lactamase inhibitors | ME1, MGAM, GAA | CDC25A 989/4885CDC25B 1424/4885ALOX15 535/4885 |
| US-20160151322-A1 | METALLO-B-LACTAMASE INHIBITORS | ME1, MGAM, MANBA | CDC25A 854/4885CDC25B 928/4885ALOX15 487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.